Package 49702-242-13

{"route": ["ORAL"], "spl_id": "155cffa3-1699-44ce-bed2-b1759c1fcf66", "openfda": {"unii": ["1Q1V9V5WYQ", "212WAX8KDD"], "rxcui": ["1989500", "1989506"], "spl_set_id": ["806653d1-bf35-4924-b999-ad5d21821cc1"], "manufacturer_name": ["ViiV Healthcare Company"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (49702-242-13)", "package_ndc": "49702-242-13", "marketing_start_date": "20171121"}], "brand_name": "Juluca", "product_id": "49702-242_155cffa3-1699-44ce-bed2-b1759c1fcf66", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["HIV Integrase Inhibitors [MoA]", "Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]", "Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]", "Non-Nucleoside Analog [EXT]", "Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Organic Cation Transporter 2 Inhibitors [MoA]"], "product_ndc": "49702-242", "generic_name": "dolutegravir sodium and rilpivirine hydrochloride", "labeler_name": "ViiV Healthcare Company", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Juluca", "active_ingredients": [{"name": "DOLUTEGRAVIR SODIUM", "strength": "50 mg/1"}, {"name": "RILPIVIRINE HYDROCHLORIDE", "strength": "25 mg/1"}], "application_number": "NDA210192", "marketing_category": "NDA", "marketing_start_date": "20171121", "listing_expiration_date": "20261231"}